ALK inhibitors are highly effective in patients with ALK-rearranged NSCLC.17,18,21,22 Thus, we also examined the effects of ALK inhibitors on RDAA lung cancer cells in vitro and in vivo. Here, ALK is linked to lung carcinoma.